VitaNova Life Sciences (VNOV) Assets (2017 - 2026)

VitaNova Life Sciences has disclosed Assets across 9 years of filings, most recently posting $2.2 million for Q3 2026.

• Assets for Q3 2026 came in at $2.2 million, changed 0.13% year-over-year; the trailing twelve-month figure through Jul 2026 was $2.2 million (changed 0.13% YoY), and the FY2026 annual result was $2.4 million, up 8.43% from the prior year.
• Assets for Q3 2026 stood at $2.2 million, down from $2.4 million in the prior quarter.
• Across five years, Assets topped out at $2.4 million in Q2 2026 and bottomed at $8728.0 in Q2 2023.
• Average Assets over 5 years is $1.2 million, with a median of $1.2 million recorded in 2024.
• The widest annual swing landed in 2023, when Assets slumped 73.97%; it then jumped 13567.03% in 2024.
• Year by year, Assets stood at $35190.0 in 2022, then sank by 75.2% to $8728.0 in 2023, then soared by 14322.69% to $1.3 million in 2024, then surged by 85.59% to $2.3 million in 2025, then decreased by 4.15% to $2.2 million in 2026.
• The last three Assets figures came in at $2.2 million (Q3 2026), $2.4 million (Q2 2026), and $2.3 million (Q1 2026), per Business Quant data.